MARKET

QLGN

QLGN

Qualigen Therapeutics Inc
NASDAQ
3.490
-0.150
-4.12%
After Hours: 3.250 -0.24 -6.87% 16:25 04/01 EDT
OPEN
3.620
PREV CLOSE
3.640
HIGH
3.780
LOW
3.210
VOLUME
947.79K
TURNOVER
--
52 WEEK HIGH
29.44
52 WEEK LOW
2.960
MARKET CAP
2.57M
P/E (TTM)
-0.0622
1D
5D
1M
3M
1Y
5Y
1D
Qualigen Therapeutics Delays Yearly Financial Report
TipRanks · 8h ago
Qualigen Therapeutics enters MOU to acquire Marizyme
TipRanks · 8h ago
Qualigen Enters $10B Coronary Artery Bypass Graft Market With Non-Binding MOU To Acquire Marizyme
Benzinga · 8h ago
*Qualigen Seeks To Enter The $10 Billion CABG Market With Non-binding MOU To Acquire Marizyme >QLGN
Dow Jones · 8h ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 1d ago
Weekly Report: what happened at QLGN last week (0324-0328)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 3d ago
Weekly Report: what happened at QLGN last week (0317-0321)?
Weekly Report · 03/24 11:59
More
About QLGN
More
Qualigen Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.
Recently
Symbol
Price
%Change

Webull offers Qualigen Therapeutics Inc stock information, including NASDAQ: QLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QLGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QLGN stock methods without spending real money on the virtual paper trading platform.